ACEi/ARB for systolic heart failure: Clo
โ
Qi Qian; Dennis M. Manning; Narith Ou; Mark J. Klarich; Dorinda J. Leutink; Ann
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 332 KB
## Abstract ## BACKGROUND: National guidelines recommend angiotensin converting enzyme inhibitor (ACEi) or angiotensinogen receptor blocker (ARB) therapy for patients with left ventricular systolic dysfunction (LVSD), including those with symptomatic heart failure (HF). However, guideline adherenc